ReviewMedicine2025
The application of microfluidic technology in allergen detection: A review.
Review in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bioassays in Allergy: Technical Characteristics, Limitations, and Pathways to Clinical Implementation-An EAACI Position Paper.Clinical and translational allergy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The escalating prevalence of allergic diseases has intensified the need for rapid and precise allergen detection, prompting the exploration of microfluidic technology in this domain. This review delves into the utility of microfluidics in enhancing allergen detection, underscoring its high sensitivity, throughput, and miniaturization advantages. We survey the spectrum of microfluidic chip materials, from silicon wafers to paper-based substrates, and discuss various fabrication techniques. The integration of microfluidics with detection methods like enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction, Western blotting, loop-mediated isothermal amplification (LAMP), and biosensors has transformed allergen diagnostics, offering more efficient, sensitive, and user-friendly platforms. These advancements facilitate point-of-care testing and hold significant potential for personalized medicine. Our review highlights the novel applications of microfluidics in allergen detection, contributing valuable insights for the development of future diagnostic tools and clinical research in allergy treatment. The innovative convergence of microfluidics with existing diagnostic methods presents a paradigm shift in the field of allergen detection, promising enhanced prevention and management of allergic diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.